Edit

https://www.hap10bio.com/
Last activity: 05.04.2023
Active
Categories: ChemicalDevelopmentDrugOwn
Hap10 is developing antibodies targeting haptens of inhibited KRAS12C. From the UCSF Labs of Charles Craik and Kevan Shokat.

Investors 1

DateNameWebsite
05.04.2023SeedFolioseedfolio....

Reviews 0

Sign up to leave a review

Sign up Log In